Understanding how Smyd1 regulates muscle development
Molecular regulation of muscle development by Smyd1
This study is looking at a protein called Smyd1 to see how it helps muscle cells grow and work properly, which could help us understand and find new ways to treat muscle diseases like muscular dystrophy and heart problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10466853 on NIH RePORTER |
What this research studies
This research investigates the role of Smyd1 in muscle cell differentiation, focusing on how it influences the assembly of proteins necessary for muscle contraction. By studying the molecular mechanisms involved, the research aims to uncover how defects in this process can lead to conditions like muscular dystrophy and cardiomyopathy. The approach includes examining the behavior of Smyd1 in both the nucleus and cytoplasm of muscle cells, where it regulates gene expression and interacts with muscle proteins. This could provide insights into potential therapeutic targets for muscle-related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic predispositions to muscular dystrophy or related muscle disorders.
Not a fit: Patients with muscle conditions unrelated to the mechanisms being studied, such as those caused by external injuries, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for muscular dystrophy and other muscle-related disorders.
How similar studies have performed: Previous research has shown promising results in understanding muscle development and related disorders, indicating that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Du, Shaojun — University of Maryland Baltimore
- Study coordinator: Du, Shaojun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.